• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Erratum to 'Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received' [European Urology 77 (2020) 320-330].

作者信息

Neal David E, Metcalfe Chris, Donovan Jenny L, Lane J Athene, Davis Michael, Young Grace J, Dutton Susan J, Walsh Eleanor I, Martin Richard M, Peters Tim J, Turner Emma L, Mason Malcolm, Bryant Richard, Bollina Prasad, Catto James, Doherty Alan, Gillatt David, Gnanapragasam Vincent, Holding Peter, Hughes Owen, Kockelbergh Roger, Kynaston Howard, Oxley Jon, Paul Alan, Paez Edgar, Rosario Derek J, Rowe Edward, Staffurth John, Altman Doug G, Hamdy Freddie C

机构信息

Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK Professor Emeritus of Surgical Oncology, Universities of Cambridge and Oxford, UK.

Bristol Randomised Trials Collaboration (BRTC), Bristol Trials Centre, University of Bristol, Bristol, UK.

出版信息

Eur Urol. 2020 Sep;78(3):e139-e143. doi: 10.1016/j.eururo.2020.05.030. Epub 2020 Jul 3.

DOI:
10.1016/j.eururo.2020.05.030
PMID:32624282
Abstract
摘要

相似文献

1
Erratum to 'Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received' [European Urology 77 (2020) 320-330].《根据接受的治疗，ProtecT随机对照试验中局部前列腺癌男性的十年死亡率、疾病进展及治疗相关副作用》的勘误[《欧洲泌尿外科杂志》77卷（2020年）320 - 330页]
Eur Urol. 2020 Sep;78(3):e139-e143. doi: 10.1016/j.eururo.2020.05.030. Epub 2020 Jul 3.
2
Re: Ten-Year Mortality, Disease Progression, and Treatment-Related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received.回复：来自 ProtecT 随机对照试验的局限性前列腺癌男性患者根据接受的治疗的十年死亡率、疾病进展及治疗相关副作用
J Urol. 2020 May;203(5):882-883. doi: 10.1097/JU.0000000000000779.02. Epub 2020 Feb 13.
3
[10-Year mortality, disease progression, and treatment-related side effects in men with localized prostate cancer from the ProtecT Randomised Controlled Trial, analyzed according to treatment received].[根据接受的治疗对ProtecT随机对照试验中局限性前列腺癌男性患者的10年死亡率、疾病进展及治疗相关副作用进行分析]
Strahlenther Onkol. 2021 Jul;197(7):651-654. doi: 10.1007/s00066-021-01789-y. Epub 2021 May 7.
4
5
Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.局限性前列腺癌的治疗：根据其自然病程（通常进展相对缓慢），可选择观察等待、手术或放射治疗。
Prescrire Int. 2012 Oct;21(131):242-8.
6
Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial.帕利泊芬血管靶向光动力疗法与主动监测治疗低危前列腺癌男性患者（CLIN1001 PCM301）：一项开放标签、3 期、随机对照临床试验。
Lancet Oncol. 2017 Feb;18(2):181-191. doi: 10.1016/S1470-2045(16)30661-1. Epub 2016 Dec 20.
7
Cryotherapy for localised prostate cancer.局部前列腺癌的冷冻疗法。
Cochrane Database Syst Rev. 2007 Jul 18(3):CD005010. doi: 10.1002/14651858.CD005010.pub2.
8
Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial.局部晚期前列腺癌男性患者的短期雄激素抑制和放疗与中期雄激素抑制和放疗，联合或不联合唑来膦酸治疗（TROG 03.04 RADAR）：一项随机、3 期、析因试验的 10 年结果。
Lancet Oncol. 2019 Feb;20(2):267-281. doi: 10.1016/S1470-2045(18)30757-5. Epub 2018 Dec 19.
9
Radical prostatectomy versus watchful waiting for prostate cancer.前列腺癌根治术与观察等待
Cochrane Database Syst Rev. 2010 Nov 10(11):CD006590. doi: 10.1002/14651858.CD006590.pub2.
10
PCASTt/SPCG-17-a randomised trial of active surveillance in prostate cancer: rationale and design.PCASTt/SPCG - 17 - 前列腺癌主动监测随机试验：原理与设计
BMJ Open. 2019 Aug 22;9(8):e027860. doi: 10.1136/bmjopen-2018-027860.